BBIO
BridgeBio Pharma, Inc. Common Stock
$66.09
-5.07%
-3.54
Notify me if price changes either direction
Buy BBIO stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
13.0B
Enterprise value
14.5B
Trailing PE
-17.4947082681
Forward PE
176.34666
PEG Ratio
0.6123147893835
Enterprise to EBITDA
-29.093
Enterprise to revenue
25.026
Price to book MRQ
-6.1637912245141
Price to sales TTM
22.333174
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
580.0M
EBITDA
-498881984
Diluted EPS TTM
-3.74
Total Cash (MRQ)
940.2M
Current ratio (MRQ)
1.521
Operating Cash Flow (TTM)
-443953984
BBIO trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
May 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
